CEO & Managing Director Marjan Mikel outlined the Company's achievements and progress in the US in a recent live webinar. If you missed it, not to worry, you can view by clicking on the video below. https://lnkd.in/gGDGPRSp
Respiri Limited
Medical Equipment Manufacturing
Melbourne, Victoria 694 followers
Care beyond the Clinic
About us
An RPM Business Augmented by R&D Respiri Limited (ASX:RSH, OTCQB:RSHUF) is a pioneering presence in the Remote Patient Monitoring (RPM) and MedTech sectors. The company uses its innovative respiratory technology with a disruptive business model as an RPM provider to offer the only RPM program for respiratory disorders. As a differentiated RPM provider, Respiri’s mission is to improve health outcomes for patients with chronic diseases from cardiovascular, diabetes, obesity and, exclusively, respiratory disease. Respiri’s globally unique medical device and its Remote Patient Monitoring services empower healthcare organisations to take action from patient data when needed, not only when scheduled. Respiri is strategically positioned to revolutionise chronic disease management globally and is focused on the US market, where RPM services are reimbursed by Current Procedural Terminology (CPT) Code reimbursement.
- Website
-
http://respiri.co/au
External link for Respiri Limited
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Melbourne, Victoria
- Type
- Public Company
- Founded
- 2006
- Specialties
- Medical devices, Asthma management, Health technology, mHealth, Medical apps, Health apps, COPD management, Patient self-management, Health innovations, Chronic disease management, Remote Patient Monitoring, and MedTech
Locations
-
Primary
Get directions
432 St Kilda Rd
Level 9
Melbourne, Victoria 3004, AU
Employees at Respiri Limited
-
George V.
-
Marjan Mikel
CEO/Managing Director at Respiri Limited
-
Kevin Dsouza
Cloud Architect | Technology Leader | AWS Community Builder | Driving Scalable, Secure Cloud Solutions
-
Peter Hildebrandt
CEO | Global Executive | Build & Grow Sustainable Businesses. Capture Markets with Technology & Innovation
Updates
-
Delivering growth and strong results. Another quarter of significant growth with 1000 patient program enrolments compared to June quarter, representing a 71% improvement. This equates to more patients benefiting from one of Respiri's many Connected Care Management Programs, whilst delivering tangible and significant reductions in overall US Healthcare expenditure. Read more: https://lnkd.in/dPDHqXJU
-
-
Respiri secures A$1.6 Million Strategic Investment. The Company welcomes high performing, institutional investor Merchant Biotech Fund and other associated prominent investors including Hamma Capital to the Company’s share register. Read more: https://lnkd.in/gAAfdBeM
-
-
Respiri is pleased to announce its first agreements with two Skilled Nursing Facilities in Hawaii, US. Our RPM programs will target ~1000 patients discharged per year from these facilities and will include Respiri's innovative Clinic in Cloud solution. You can read more by following the link below https://lnkd.in/gxty93Vz
-
-
If you missed yesterday's exciting market update by our CEO & MD Marjan Mikel, you can watch by clicking below!
Respiri Limited Business Update Investor Presentation 31 July 2024
https://vimeo.com/
-
Respiri is pleased to invite shareholders and investors to a webinar on Wednesday 31 July 2024 at 11:00am AEST, where Managing Director Marjan Mikel will provide additional detail around the significant milestones achieved in the June quarter, as reported in the Company 4C, and engage in a Q&A session. Link below to register: https://lnkd.in/geAbANHT
-
-
Respiri is pleased to share its recent June Quarter 4C 2024 ASX announcement. With a record enrolment of patients on programs, which represents a 4 fold increase in patient numbers from the previous quarter... Link here to view full announcement. https://lnkd.in/g4vDYWqd
-
-
Respiri Limited reposted this
Dear Robyn, thank you for the opportunity to be part of this session and allowing us to share our success stories and the inevitable trials and tribulations that come along with this journey we know as success!
Executive Leader | Strategic Partnerships | Strategy development and implementation | Health | Science
It was a pleasure and privilege to help kick off #ausmedtech2024 yesterday with this panel of Australian industry leaders. Thank you Jerneen Williams Sam Lanyon Paul Anderson and Marjan Mikel for sharing your stories and learned insights of the road to success and the potholes along the way. Some key takeaways: - Being focussed and flexible, - Having the right people at the right time, - Not being seduced by your technology, it’s just one part of the story - Acknowledging that you can’t and don’t know it all - Being bold Orthocell Ltd Bellberry Respiri Limited Lumos Diagnostics AusBiotech
-
-
Respiri Limited reposted this
Spotlight on innovation: Australian success stories at AusMedtech 2024 🌟 Join us for an insightful panel discussion at AusMedtech 2024 where we celebrate the significant achievements of Australian medtech companies. In this session chaired by Robyn Lindner, General Manager, AusBioNSW, hear first-hand from the pioneers who are driving technological advancements, including: • Sam Lanyon, Executive Director, Lumos • Marjan Mikel, Chief Executive Officer & Managing Director, Respiri Limited • Paul Anderson, Chief Executive Officer & Managing Director, Orthocell Ltd • Jerneen Williams, Director of Operations, Bellberry Limited Don't miss this opportunity to draw inspiration from the top minds in our industry and discover how collaboration and innovation lead to success. #AusMedtech2024 #AMT24 #AustralianSuccess #MedtechInnovation
-